On March 6, upon reconsideration, the Senate failed to pass SB 1085 by one vote. This bill would have authorized pharmacists to test and initiate treatment for conditions such as influenza, COVID, strep and other respiratory illnesses and to delegate the administrative and technical tasks of performing a test to a trained member of the pharmacy staff who is under the supervision of the pharmacist.
Also in Arizona, this week, the Department of Health Services (ADHS) launched a naloxone campaign aimed at combating the state’s opioid overdose crisis. This multi-media campaign features stories from a diverse group of Arizonans whose lives were impacted by naloxone, connects those with substance use disorder to support resources, and demonstrates how to use naloxone to save lives. The FDA-approved injectable and nasal spray formulations are available over the counter, at pharmacies, community-based distribution programs, and through local health departments, making it possible for the public to also utilize naloxone to save lives. The ADHS encourages individuals to get it without a prescription at your local pharmacy.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.